2 Cheap Healthcare Stocks to Buy Now
It's time to shop for healthcare stocks that have suffered so far this year but should rebound in the long term thanks to growth drivers waiting in the wings. The first of these great deals, a pharmaceutical company, has a blockbuster on the market, a newer drug with growing sales, and possible drug approvals in the coming months. And the second great deal is a diagnostics player with a huge opportunity in cancer screening.
Image source: Getty Images.
Jazz Pharmaceuticals (NASDAQ: JAZZ), a maker of sleep therapeutics and oncology drugs, has steadily grown annual revenue for more than a decade, announcing record annual revenue for 2019. Total revenue climbed 14% to $2.2 billion, and net product sales of blockbuster narcolepsy drug Xyrem increased 17% to $1.6 billion.
Source Fool.com
